$SIBN News
Last published 1d ago
- 1d agoSIBNSI-BONE, Inc. - 1781346 - SI-BONE INCEarnings Call TranscriptsAll righty. Thank you so much, everybody, for joining. Really appreciate it. Obviously, Patrick on the U.S. MedTech team, last session of the day, and very excited. Savanchil is Chief Financial Officer here from SI Byrne
- 1w agoSIBNSI-BONE, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 9.01
- 1w agoSIBNSI-BONE, Inc. Reports Financial Results for the Third Quarter 2026 and Reaffirms 2026 Revenue GuidanceGlobeNewswireDelivered ~20% U.S. procedure volume growth in the third quarter Third Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $55.7 million, representing growth of
- 1w agoSIBNSI-BONE Third Quarter 2026 Earnings Call - SI-BONE INCEarnings Call TranscriptsGood afternoon and welcome to Seabone's third quarter 2026 earnings conference call. At this time, all participants are in listen-only mode. We will be facilitating a question and answer session towards the end of today'
- 1w agoSIBNSI-BONE To Present at UBS Global Healthcare Conference on November 10, 2026GlobeNewswireSAN JOSE, Calif., Oct. 29, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced
- 3w agoSIBNSI-BONE To Report Third Quarter 2026 Financial Results on November 2, 2026GlobeNewswireSAN JOSE, Calif., Oct. 19, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced it
- 1mo agoSIBNSI-BONE, Inc. - 1774169 - SI-BONE INCEarnings Call TranscriptsHello. Good morning, everyone. Thanks for joining us today. I'm Eduardo Herden. I am part of the Morgan Stanley team. Today I have the pleasure of being joined by Anshul Maheshwari, CEO and CFO of SI Bone. Before we begi
- 1mo agoSIBNMorgan Stanley 24th Annual Global Healthcare Conference - SI-BONE INCEarnings Call TranscriptsHello. Good morning, everyone. Thanks for joining us today. I'm Eduardo Herden. I am part of the Morgan Stanley team. Today I have the pleasure of being joined by Anshul Maheshwari, CEO and CFO of SI Bone. Before we begi
- 2mo agoSIBNSI-BONE To Present at Morgan Stanley 24th Global Healthcare Conference on September 14, 2026GlobeNewswireSANTA CLARA, Calif., Aug. 31, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced
- 3mo agoSIBNSI-BONE, Inc. Reports Financial Results for the Second Quarter 2026 and Raises 2026 GuidanceGlobeNewswireDelivered ~15% WW revenue growth and ~178% increase in adjusted EBITDA ~19% increase in U.S. physician base Second Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide
- 3mo agoSIBNSI-BONE To Report Second Quarter 2026 Financial Results on August 3, 2026GlobeNewswireSANTA CLARA, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced
- 4mo agoSIBNViCentra Appoints Ian Wells as Chief Financial Officer and Adds Medtech Veteran Tom West to its BoardGlobeNewswireIan Wells, former Global Chief Financial Officer of HOYA Vision Care, appointed CFO, bringing multi-billion-dollar P&L leadership and capital-markets disciplineTom West, who led Intersect ENT to its $1.1 billion
- 5mo agoSIBNSI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026GlobeNewswireSANTA CLARA, Calif., June 04, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced
- 6mo agoSIBNSI-BONE to Report Operating Results for the First Quarter 2026SI-BONE INCEarnings Call TranscriptsGood afternoon and welcome to SI Bones first quarter 2026 earnings conference call. At this time all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of today's
- 6mo agoSIBNSI-BONE, Inc. Reports Financial Results for the First Quarter 2026 and Raises 2026 GuidanceGlobeNewswireFirst Quarter 2026 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $52.6 million, representing growth of 11.2%U.S. revenue of $49.3 million, representing growth of 10.0%Gross
- 6mo agoSIBNSI-BONE To Present at BofA Securities 2026 Healthcare Conference on May 12, 2026GlobeNewswireSANTA CLARA, Calif., April 30, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced
- 6mo agoSIBNSI-BONE To Report First-Quarter 2026 Financial Results on May 11, 2026GlobeNewswireSANTA CLARA, Calif., April 20, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced
- 8mo agoSIBNSNNSmith+Nephew signs distribution agreement with SI-BONEGlobeNewswireTrauma and Extremities partnership aligns disciplined approach to portfolio optimization and focuses on delivering long-term value for surgeons and patients Smith+Nephew ((LSE:SN, NYSE:SNN), the global medical
- 8mo agoSIBNSI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2025 and Issues 2026 GuidanceGlobeNewswireAchieves 20% worldwide revenue growth and positive adjusted EBITDA for Fiscal Year 2025Generates free cash flow in the Fourth Quarter 2025 SANTA CLARA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc.
- 8mo agoSIBNSI-BONE To Present at TD Cowen 46th Annual Health Care Conference on March 2, 2026GlobeNewswireSANTA CLARA, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced
- 9mo agoSIBNSI-BONE To Report Fourth-Quarter and Full-Year 2025 Financial Results on February 23, 2026GlobeNewswireSANTA CLARA, Calif., Feb. 02, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced
- 10mo agoSIBNSI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025GlobeNewswireSANTA CLARA, Calif., Jan. 12, 2026 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), the global leader in developing procedural solutions to address clinical challenges associated with compromised bone, today announced
- 11mo agoSIBNSI-BONE To Present at Piper Sandler 37th Annual Healthcare Conference on December 2, 2025GlobeNewswireSANTA CLARA, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the
- 1y agoSIBNSI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 GuidanceGlobeNewswireDelivered ~21% worldwide revenue growth, ~5% adjusted EBITDA margin, and positive cash from operating activities in the quarter Third Quarter 2025 Financial Highlights (all comparisons are to the prior year period)
- 1y agoSIBNSI-Bone Inc. - Appeal, ReversedUS Patent Trial and Appeal Board
- 1y agoSIBNSI-BONE To Report Third Quarter 2025 Financial Results on November 10, 2025GlobeNewswireSANTA CLARA, Calif., Oct. 20, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the third
- 1y agoSIBNSI-BONE, Inc. (SIBN) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Earnings Call Transcripts
- 1y agoSIBNSI-BONE to Present at Morgan Stanley 23rd Global Healthcare Conference on September 9, 2025GlobeNewswireSANTA CLARA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the
- 1y agoSIBNSI-BONE, Inc. (SIBN) Q2 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoSIBNSI-BONE, Inc. Reports Financial Results for the Second Quarter 2025 and Raises 2025 GuidanceGlobeNewswireSecond Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $48.6 million, representing growth of 21.7%U.S. revenue of $46.4 million, representing growth of 22.8%Gross
- 1y agoSIBNSI-BONE To Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025GlobeNewswireSANTA CLARA, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the
- 1y agoSIBNSI-BONE To Report Second Quarter 2025 Financial Results on August 4, 2025GlobeNewswireSANTA CLARA, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the second
- 1y agoSIBNSI-BONE to Truist Securities MedTech Conference on June 17, 2025GlobeNewswireSANTA CLARA, Calif., June 04, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the
- 1y agoSIBNSI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025GlobeNewswireSANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the
- 1y agoSIBNSI-BONE To Present at BofA Securities 2025 Healthcare Conference on May 13, 2025GlobeNewswireSANTA CLARA, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the
- 1y agoSIBNSI-BONE, Inc. Reports Financial Results for the First Quarter 2025 and Updates 2025 GuidanceGlobeNewswireFirst Quarter 2025 Financial Highlights (all comparisons are to the prior year period) Worldwide revenue of $47.3 million, representing growth of 24.9%U.S. revenue of $44.8 million,
- 1y agoSIBNSI-BONE To Report First Quarter 2025 Financial Results on May 5, 2025GlobeNewswireSANTA CLARA, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the first
- 1y agoSIBNSI-BONE, Inc. Reports Record Financial Results for the Fourth Quarter 2024 and Issues 2025 GuidanceGlobeNewswireSANTA CLARA, Calif., Feb. 24, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today reported financial results for the fourth quarter and full
- 1y agoBRKRPGNYSIBNSWAVBruker Appoints Laura Francis to its Board of DirectorsBusiness WireBruker Corporation (NASDAQ:BRKR) today announced that its Board of Directors has appointed Laura Francis to serve on its board as an independent director, effective as of February 18, 2025. Ms. Francis is also expected
- 1y agoSIBNSI-BONE to Report Fourth-Quarter and Full-Year 2024 Financial Results on February 24, 2025GlobeNewswireSANTA CLARA, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the fourth
- 1y agoSIBNSI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2024GlobeNewswireFourth Quarter 2024 worldwide revenue of ~$48.8 to $49.0 million representing growth of ~26%Achieved adjusted EBITDA profitability in the fourth quarter SANTA CLARA, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- SI-BONE,
- 1y agoSIBNSI-BONE To Present at Piper Sandler 36th Annual Healthcare Conference on December 4, 2024GlobeNewswireSANTA CLARA, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the
- 1y agoSIBNSI-BONE, Inc. (SIBN) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoSIBNSI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates GuidanceGlobeNewswireSANTA CLARA, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today reported financial results for the quarter ended September
- 2y agoSIBNSI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™GlobeNewswireSANTA CLARA, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (NASDAQ:SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, today announced
- 2y agoSIBNSI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024GlobeNewswireSANTA CLARA, Calif., Oct. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will report financial results for the third
- 2y agoSIBNSI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture FixationGlobeNewswireSANTA CLARA, Calif., Oct. 10, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, today announced
- 2y agoSIBNSI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024GlobeNewswireSANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the
- 2y agoSIBNSI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation SystemGlobeNewswireSANTA CLARA, Calif., Aug. 20, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (NASDAQ:SIBN), a Silicon Valley-based medical device company dedicated to providing surgical solutions for sacropelvic disorders, announces FDA
- 2y agoSIBNSI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024GlobeNewswireSANTA CLARA, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (NASDAQ:SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced it will be participating in the upcoming 2024